Adding Another Success Story with BFDA's GMP Renewal!

26 January, 2024

We warmly welcomed a 6-member Bhutan Food and Drug Authority team as they visited our ABHL plant for the GMP certificate renewal audit from January 24-26, 2024. We are excited to announce the audit's success, reaffirming our commitment to excellence. To mark this milestone, we captured memorable moments with the BFDA team during their visit and are grateful to the BFDA team for their meticulous evaluation and collaboration. We are delighted that collaboratively, we are paving the way for excellence in the pharmaceutical industry!

Azista Bhutan Audit Concludes: A Blend of Productivity and Sustainability.

14th November 2023

Azista Bhutan Audit Concludes: A Blend of Productivity and Sustainability.

Azista Bhutan’s Audit Close Meet and Greet, concluded with seamlessly merged productivity, sustainability, and enjoyment. In addition to finalizing the audit, participants actively contributed to environmental sustainability by planting saplings, aligning with Azista Bhutan's team fun activities.

The event also featured team-building activities, fostering camaraderie among participants. These engaging activities, alongside the audit's meticulous attention to detail, aimed to ensure accuracy, transparency, and compliance.

The positive outcomes of the audit lay the groundwork for continuous improvement within Azista Bhutan. Insights gained from both the audit and collaborative activities will shape future organizational strategies, maintaining a focus on excellence, sustainability, and a positive workplace culture.

Contact Us

To order or to know more details about Menthopas, reach us by filling the form. We will get back you within 1-2 business days.

Corporate Office

Hetero Healthcare Limited
Sy.No 80-84, Melange Towers,
4th Floor, C Wing, Patrika Nagar,
Madhapur, Hyderabad, Telangana
500081, India.

Marketing Offfice

Hetero Healthcare Limited
A-202/B201, Dipit Classic,
32/34, W.T.Suren Road,
Andheri(East), Mumbai, Maharashtra
400093, India.

Call us to talk

Send us a question

Follow Us

0/600